The notable advances on interstitial lung disease(ILD)published in Chinese and international authoritative journals from October 2023 to September 2024 were systematically reviewed in this annual review.Advances on pathogenesis,diagnosis,treatment,global and/or Chinese comments and guidelines of idiopathic pulmonary fibrosis,connective tissue disease-associated ILD and sarcoidosis were reviewed in detail in our paper.
NETL
NSTL
万方数据
